Physician profile
Guanning Lu
NPI 1558604728
$7,315.57
in general payments reported to CMS, 2019-2025
8 companies · $2,104 in 2025
The $2,104 reported for 2025 was more than what 93% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $125 · 2021: $133 · 2022: $170 · 2023: $2,792 · 2024: $1,792 · 2025: $2,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Travel and Lodging: $1,968 · Consulting Fee: $1,000 · Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Travel and Lodging | $1,967.82 |
| Consulting Fee | $1,000.00 |
| Food and Beverage | $719.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $6,116.71 | 2023-2025 | |
| Stryker Corporation | $481.88 | 2022-2023 | Na, Smartlock, Xpress Ent Dilation System |
| Merz Pharmaceuticals, LLC | $142.68 | 2024 | Xeomin |
| Allergan, INC. | $133.15 | 2021 | |
| Horizon Therapeutics Plc | $125.00 | 2020 | |
| Intersect Ent, INC. | $123.64 | 2019 | |
| Kls-Martin L.P. | $116.00 | 2025 | |
| Depuy Synthes Sales INC. | $76.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guanning Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.